Stifel raises target price on MBX Biosciences to $84 from $70
MBX•Stifel raised its target price on MBX Biosciences to $84 from $70.
Related News
Antero Resources Corporation: Raymond James raises target price to $58 from $55
AR•
Evercore hires Baird’s John Song, Jean Stack as senior managing directors in aerospace, defense banking
EVR•
StoneX raises Cantor Equity Partners II target price to $18 from $12
SECZ•
IDEXX Laboratories: KeyBanc initiates coverage with Sector Weight rating
IDXX•
Builders FirstSource Inc: BMO cuts target price to $68 from $80
BLDR•